arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Apyx Medical Corp

APYX
$2.84 ▼ -0.12 (-3.89%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Apyx Medical Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $116.7M
Dividend Yield —
Revenue Growth 9.9% ↗
Op. Margin -12.2% ↗
ROIC -12.7% ↗
FCF / Share $-0.22 ↗
Trailing P/E —
Price / Book 8.2x
FCF Yield —
Debt / Equity 2.58
info Valuation on last close. End-of-day price, Sep 24, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$52.84M
↑ +9.9% —
Net Income Profit after all expenses
$-11.21M
↑ +52.2% —
Operating Margin Operating profit as % of sales
-12.2%
↑ +68.9% 14th
FCF / Share Free cash flow per share
$-0.22
↑ +58.0% —
Long-Term Debt Long-term obligations
$37.50M
— 0.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
11
Returns ↓
12
Financial Health ↑
27
Cash Quality ↑
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 18 years · 68 quarters